In Vivo Assessment of Combined Effects of Glibenclamide and Losartan in Diabetic Rats
Conclusion: Adding LT to GLI therapy revealed prospective antioxidant and anti-inflammatory action, while no synergistic or additive effects were observed.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research
More News: Antidoxidants | Cozaar | Diabetes | Endocrinology | Insulin | Internal Medicine | Liver | Losartan | Study | Urology & Nephrology